All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 3, 2022
Home » Topics » Financings, BioWorld Asia

Financings, BioWorld Asia
Financings, BioWorld Asia RSS Feed RSS

Globe and currency symbols

Final tally comes in at $118B, second top financings amount in biopharma history

Jan. 11, 2022
By Karen Carey
No Comments
While the $118.3 billion raised by biopharma companies in 2021 through public and private transactions is 12% lower than the amount raised the prior year, it still represents an impressive financings record, led primarily by IPOs and venture capital rounds.
Read More

Financings for Jan. 11, 2022

Jan. 11, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Accro, Atom Bioscience, Bionomics, Cellusion, Chance, Hanmi, Innate, Spectrum.
Read More
RNA illustration

Sirnaomics starts 2022 with $64M Hong Kong IPO

Jan. 4, 2022
By Doris Yu
No Comments
Sirnaomics Ltd. became the first RNA therapeutics company to list on the Hong Kong Stock Exchange (HKEX) with a $64 million initial public offering. Its shares (HKEX:2277) have since surged, rising to HK$93.90 ($12.04) on Jan. 4 following their debut at HK$65.90 per share.
Read More

Financings for Jan. 4, 2022

Jan. 4, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Biondvax, Genfleet.
Read More

Xuanzhu Biopharm raises $96M in series B round to fund phase III trials

Jan. 4, 2022
By Doris Yu
No Comments
Sihuan Pharmaceutical Holdings Group Ltd.’s subsidiary Xuanzhu Biopharmaceutical Co. Ltd. has raised ¥610.5 million ($96 million) in a series B round led by Sunshine Life Insurance Corp. Ltd.
Read More

Financings for Dec. 28, 2021

Dec. 28, 2021
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Northview Acquisition.
Read More

Financings for Dec. 21, 2021

Dec. 21, 2021
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Beroni, Bionomics, Cargene, Propanc.
Read More
3D dollar sign

Anheart Therapeutics raises $61M in series B for precision oncology pipeline

Dec. 21, 2021
By Doris Yu
No Comments
Anheart Therapeutics Co. Ltd. raised $61 million in a series B round to support the development of a slate of precision oncology pipeline in-licensed by the company from Daiichi Sankyo Co. Ltd. Toward that end, funds will support phase II testing of the Hangzhou, China-based firm’s lead asset, the ROS1 inhibitor taletrectinib, for the potential treatment of non-small-cell lung cancer.
Read More

Beigene’s $3.4B Shanghai IPO loses steam on first trading day

Dec. 21, 2021
By Doris Yu
No Comments
Beigene Ltd.’s listing on the Shanghai STAR Market netted ¥22 million ($3.4 billion) as the company became making it the first biotech firm to be listed on Nasdaq, the Hong Kong Stock Exchange, and the Shanghai STAR Market. But Shanghai shares, initially priced at ¥192.6 each, fizzled quickly, plunging over 16.4% by market close to ¥160.98 on Dec. 15.
Read More
Hand holding gear, dollar sign

Avistone raises $200M, acquires Pearl Biotech

Dec. 14, 2021
By Doris Yu
No Comments
Avistone Biotechnology Co. Ltd. raised more than $200 million to support its oncology drug development and the acquisition Pearl Biotechnology Co. Ltd. with the aim of creating a “fully-integrated” targeted oncology platform. Vivo Capital LLC led the financing, with participation from Bain Capital LP. and Primavera Capital Group.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 33 34 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for July 1.
  • Novavax-COVID-19-vaccine-vial

    Novavax vaccine shows its chops

    BioWorld
    Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...
  • Blood sample, DNA

    Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

    BioWorld
    The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...
  • Cells and DNA helix

    Bluebird’s eli-cel gene therapy for CALD snatches adcom victory from jaws of defeat

    BioWorld
    The Cellular, Tissue and Gene Therapies Advisory Committee scrutinized Bluebird Bio Inc.’s gene therapy elivaldogene autotemcel (eli-cel) for early active...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing